March 2 (Reuters) - Beigene Ltd 6160.HK :
* HEALTH CANADA APPROVES BRUKINSA® (ZANUBRUTINIB) FOR THE TREATMENT OF WALDENSTRÖM'S MACROGLOBULINEMIA
* BEIGENE LTD - RECOMMENDED TOTAL DAILY DOSE OF BRUKINSA IS 320MG, EXPECTED TO BE AVAILABLE IN CANADA IN COMING WEEKS